Global Pegfilgrastim Biosimilar Market Research Report 2025(Status and Outlook)

March 2025 | 215 pages | ID: G5E74046D6EFEN
Bosson Research

Abstracts

Report Overview

Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in the market. Pegfilgrastim is used as a supportive oncology drug to treat chemotherapy- and/or radiotherapy-induced neutropenia in cancer patients. With more than ten pegfilgrastim biosimilars available in the market and over 5 under development, the pegfilgrastim biosimilar size market is expected to witness an upswing in the future.

This report provides a deep insight into the global Pegfilgrastim Biosimilar market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pegfilgrastim Biosimilar Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pegfilgrastim Biosimilar market in any manner.

Global Pegfilgrastim Biosimilar Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Mylan

Coherus BioSciences

Mundipharma International

Biocon

Intas Pharmaceuticals

Pfizer

Dr Reddy’s Laboratories

Market Segmentation (by Type)

Chemotherapy Treatment

Transplantation

Market Segmentation (by Application)

Hospital Pharmacies

Mail-Order Pharmacies

Retail Pharmacies

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pegfilgrastim Biosimilar Market
• Overview of the regional outlook of the Pegfilgrastim Biosimilar Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pegfilgrastim Biosimilar Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pegfilgrastim Biosimilar
1.2 Key Market Segments
  1.2.1 Pegfilgrastim Biosimilar Segment by Type
  1.2.2 Pegfilgrastim Biosimilar Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL PEGFILGRASTIM BIOSIMILAR MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pegfilgrastim Biosimilar Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Pegfilgrastim Biosimilar Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL PEGFILGRASTIM BIOSIMILAR MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pegfilgrastim Biosimilar Product Life Cycle
3.3 Global Pegfilgrastim Biosimilar Sales by Manufacturers (2020-2025)
3.4 Global Pegfilgrastim Biosimilar Revenue Market Share by Manufacturers (2020-2025)
3.5 Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pegfilgrastim Biosimilar Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Pegfilgrastim Biosimilar Manufacturing Sites, Area Served, Product Type
3.8 Pegfilgrastim Biosimilar Market Competitive Situation and Trends
  3.8.1 Pegfilgrastim Biosimilar Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pegfilgrastim Biosimilar Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PEGFILGRASTIM BIOSIMILAR INDUSTRY CHAIN ANALYSIS

4.1 Pegfilgrastim Biosimilar Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEGFILGRASTIM BIOSIMILAR MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pegfilgrastim Biosimilar Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Pegfilgrastim Biosimilar Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL PEGFILGRASTIM BIOSIMILAR MARKET BY REGION

6.1 Global Pegfilgrastim Biosimilar Market Size by Region
  6.1.1 Global Pegfilgrastim Biosimilar Market Size by Region
  6.1.2 Global Pegfilgrastim Biosimilar Market Size Market Share by Region
6.2 Global Pegfilgrastim Biosimilar Sales by Region
  6.2.1 Global Pegfilgrastim Biosimilar Sales by Region
  6.2.2 Global Pegfilgrastim Biosimilar Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Pegfilgrastim Biosimilar Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Pegfilgrastim Biosimilar Market Size by Type
7.3 North America Pegfilgrastim Biosimilar Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Pegfilgrastim Biosimilar Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Pegfilgrastim Biosimilar Market Size by Type
8.3 Europe Pegfilgrastim Biosimilar Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Pegfilgrastim Biosimilar Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Pegfilgrastim Biosimilar Market Size by Type
9.3 Asia-Pacific Pegfilgrastim Biosimilar Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Pegfilgrastim Biosimilar Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Pegfilgrastim Biosimilar Market Size by Type
10.3 South America Pegfilgrastim Biosimilar Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Type
11.3 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Application

12 PEGFILGRASTIM BIOSIMILAR MARKET PRODUCTION BY REGION

12.1 Global Production of Pegfilgrastim Biosimilar by Region(2020-2025)
12.2 Global Pegfilgrastim Biosimilar Revenue Market Share by Region (2020-2025)
12.3 Global Pegfilgrastim Biosimilar Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Pegfilgrastim Biosimilar Production
  12.4.1 North America Pegfilgrastim Biosimilar Production Growth Rate (2020-2025)
  12.4.2 North America Pegfilgrastim Biosimilar Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Pegfilgrastim Biosimilar Production
  12.5.1 Europe Pegfilgrastim Biosimilar Production Growth Rate (2020-2025)
  12.5.2 Europe Pegfilgrastim Biosimilar Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Pegfilgrastim Biosimilar Production (2020-2025)
  12.6.1 Japan Pegfilgrastim Biosimilar Production Growth Rate (2020-2025)
  12.6.2 Japan Pegfilgrastim Biosimilar Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Pegfilgrastim Biosimilar Production (2020-2025)
  12.7.1 China Pegfilgrastim Biosimilar Production Growth Rate (2020-2025)
  12.7.2 China Pegfilgrastim Biosimilar Production, Revenue, Price and Gross Margin (2020-2025)

13 PEGFILGRASTIM BIOSIMILAR MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Pegfilgrastim Biosimilar Sales Market Share by Type (2020-2033)
13.3 Global Pegfilgrastim Biosimilar Market Size Market Share by Type (2020-2033)
13.4 Global Pegfilgrastim Biosimilar Price by Type (2020-2033)

14 PEGFILGRASTIM BIOSIMILAR MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Pegfilgrastim Biosimilar Market Sales by Application (2020-2033)
14.3 Global Pegfilgrastim Biosimilar Market Size (M USD) by Application (2020-2033)
14.4 Global Pegfilgrastim Biosimilar Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Novartis
  15.1.1 Novartis Basic Information
  15.1.2 Novartis Pegfilgrastim Biosimilar Product Overview
  15.1.3 Novartis Pegfilgrastim Biosimilar Product Market Performance
  15.1.4 Novartis Business Overview
  15.1.5 Novartis SWOT Analysis
  15.1.6 Novartis Recent Developments
15.2 Mylan
  15.2.1 Mylan Basic Information
  15.2.2 Mylan Pegfilgrastim Biosimilar Product Overview
  15.2.3 Mylan Pegfilgrastim Biosimilar Product Market Performance
  15.2.4 Mylan Business Overview
  15.2.5 Mylan SWOT Analysis
  15.2.6 Mylan Recent Developments
15.3 Coherus BioSciences
  15.3.1 Coherus BioSciences Basic Information
  15.3.2 Coherus BioSciences Pegfilgrastim Biosimilar Product Overview
  15.3.3 Coherus BioSciences Pegfilgrastim Biosimilar Product Market Performance
  15.3.4 Coherus BioSciences Business Overview
  15.3.5 Coherus BioSciences SWOT Analysis
  15.3.6 Coherus BioSciences Recent Developments
15.4 Mundipharma International
  15.4.1 Mundipharma International Basic Information
  15.4.2 Mundipharma International Pegfilgrastim Biosimilar Product Overview
  15.4.3 Mundipharma International Pegfilgrastim Biosimilar Product Market Performance
  15.4.4 Mundipharma International Business Overview
  15.4.5 Mundipharma International Recent Developments
15.5 Biocon
  15.5.1 Biocon Basic Information
  15.5.2 Biocon Pegfilgrastim Biosimilar Product Overview
  15.5.3 Biocon Pegfilgrastim Biosimilar Product Market Performance
  15.5.4 Biocon Business Overview
  15.5.5 Biocon Recent Developments
15.6 Intas Pharmaceuticals
  15.6.1 Intas Pharmaceuticals Basic Information
  15.6.2 Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Overview
  15.6.3 Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Market Performance
  15.6.4 Intas Pharmaceuticals Business Overview
  15.6.5 Intas Pharmaceuticals Recent Developments
15.7 Pfizer
  15.7.1 Pfizer Basic Information
  15.7.2 Pfizer Pegfilgrastim Biosimilar Product Overview
  15.7.3 Pfizer Pegfilgrastim Biosimilar Product Market Performance
  15.7.4 Pfizer Business Overview
  15.7.5 Pfizer Recent Developments
15.8 Dr Reddy’s Laboratories
  15.8.1 Dr Reddy’s Laboratories Basic Information
  15.8.2 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Overview
  15.8.3 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Market Performance
  15.8.4 Dr Reddy’s Laboratories Business Overview
  15.8.5 Dr Reddy’s Laboratories Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 4. Global Pegfilgrastim Biosimilar Market Size by Application (M USD)
Table 5. Pegfilgrastim Biosimilar Market Size Comparison by Region (M USD)
Table 6. Global Pegfilgrastim Biosimilar Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pegfilgrastim Biosimilar Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pegfilgrastim Biosimilar Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pegfilgrastim Biosimilar Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pegfilgrastim Biosimilar as of 2024)
Table 11. Global Market Pegfilgrastim Biosimilar Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Pegfilgrastim Biosimilar Manufacturing Sites and Area Served
Table 13. Manufacturers Pegfilgrastim Biosimilar Product Type
Table 14. Global Pegfilgrastim Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pegfilgrastim Biosimilar Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Pegfilgrastim Biosimilar Market Size Comparison by Region (M USD)
Table 26. Global Pegfilgrastim Biosimilar Market Size by Region (2020-2033) & (M USD)
Table 27. Global Pegfilgrastim Biosimilar Market Size Market Share by Region (2020-2033)
Table 28. Global Pegfilgrastim Biosimilar Sales by Region (2020-2033) & (K MT)
Table 29. Global Pegfilgrastim Biosimilar Sales Market Share by Region (2020-2033)
Table 30. North America Pegfilgrastim Biosimilar Market Size by Country (2020-2033) & (M USD)
Table 31. North America Pegfilgrastim Biosimilar Sales by Country (2020-2033) & (K MT)
Table 32. North America Pegfilgrastim Biosimilar Sales by Type (K MT)
Table 33. North America Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 34. North America Pegfilgrastim Biosimilar Sales (K MT) by Type (2020-2033)
Table 35. North America Pegfilgrastim Biosimilar Market Size (M USD) by Type (2020-2033)
Table 36. North America Pegfilgrastim Biosimilar Sales by Application (K MT)
Table 37. North America Pegfilgrastim Biosimilar Market Size by Application (M USD)
Table 38. North America Pegfilgrastim Biosimilar Sales (K MT) by Application (2020-2033)
Table 39. North America Pegfilgrastim Biosimilar Market Size (M USD) by Application (2020-2033)
Table 40. Europe Pegfilgrastim Biosimilar Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Pegfilgrastim Biosimilar Sales by Country (2020-2033) & (K MT)
Table 42. Europe Pegfilgrastim Biosimilar Sales by Type (K MT)
Table 43. Europe Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 44. Europe Pegfilgrastim Biosimilar Sales (K MT) by Type (2020-2033)
Table 45. Europe Pegfilgrastim Biosimilar Market Size (M USD) by Type (2020-2033)
Table 46. Europe Pegfilgrastim Biosimilar Sales by Application (K MT)
Table 47. Europe Pegfilgrastim Biosimilar Market Size by Application (M USD)
Table 48. Europe Pegfilgrastim Biosimilar Sales (K MT) by Application (2020-2033)
Table 49. Europe Pegfilgrastim Biosimilar Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Pegfilgrastim Biosimilar Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Pegfilgrastim Biosimilar Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Pegfilgrastim Biosimilar Sales by Type (K MT)
Table 53. Asia-Pacific Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 54. Asia-Pacific Pegfilgrastim Biosimilar Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Pegfilgrastim Biosimilar Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Pegfilgrastim Biosimilar Sales by Application (K MT)
Table 57. Asia-Pacific Pegfilgrastim Biosimilar Market Size by Application (M USD)
Table 58. Asia-Pacific Pegfilgrastim Biosimilar Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Pegfilgrastim Biosimilar Market Size (M USD) by Application (2020-2025)
Table 60. South America Pegfilgrastim Biosimilar Market Size by Country (2020-2033) & (M USD)
Table 61. South America Pegfilgrastim Biosimilar Sales by Country (2020-2033) & (K MT)
Table 62. South America Pegfilgrastim Biosimilar Sales by Type (K MT)
Table 63. South America Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 64. South America Pegfilgrastim Biosimilar Sales (K MT) by Type (2020-2033)
Table 65. South America Pegfilgrastim Biosimilar Market Size (M USD) by Type (2020-2033)
Table 66. South America Pegfilgrastim Biosimilar Sales by Application (K MT)
Table 67. South America Pegfilgrastim Biosimilar Market Size by Application (M USD)
Table 68. South America Pegfilgrastim Biosimilar Sales (K MT) by Application (2020-2033)
Table 69. South America Pegfilgrastim Biosimilar Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Pegfilgrastim Biosimilar Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Pegfilgrastim Biosimilar Sales by Type (K MT)
Table 73. Middle East and Africa Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 74. Middle East and Africa Pegfilgrastim Biosimilar Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Pegfilgrastim Biosimilar Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (K MT)
Table 77. Middle East and Africa Pegfilgrastim Biosimilar Market Size by Application (M USD)
Table 78. Middle East and Africa Pegfilgrastim Biosimilar Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Pegfilgrastim Biosimilar Market Size (M USD) by Application (2020-2033)
Table 80. Global Pegfilgrastim Biosimilar Production (K MT) by Region(2020-2025)
Table 81. Global Pegfilgrastim Biosimilar Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Pegfilgrastim Biosimilar Revenue Market Share by Region (2020-2025)
Table 83. Global Pegfilgrastim Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Pegfilgrastim Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Pegfilgrastim Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Pegfilgrastim Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Pegfilgrastim Biosimilar Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Pegfilgrastim Biosimilar Sales by Type (K MT)
Table 89. Global Pegfilgrastim Biosimilar Market Size by Type (M USD)
Table 90. Global Pegfilgrastim Biosimilar Sales (K MT) by Type (2020-2033)
Table 91. Global Pegfilgrastim Biosimilar Sales Market Share by Type (2020-2033)
Table 92. Global Pegfilgrastim Biosimilar Market Size (M USD) by Type (2020-2033)
Table 93. Global Pegfilgrastim Biosimilar Market Size Share by Type (2020-2033)
Table 94. Global Pegfilgrastim Biosimilar Sales (K MT) by Application
Table 95. Global Pegfilgrastim Biosimilar Market Size by Application(M USD)
Table 96. Global Pegfilgrastim Biosimilar Sales by Application (2020-2033) & (K MT)
Table 97. Global Pegfilgrastim Biosimilar Sales Market Share by Application (2020-2033)
Table 98. Global Pegfilgrastim Biosimilar Market Size by Application (2020-2033) & (M USD)
Table 99. Global Pegfilgrastim Biosimilar Market Share by Application (2020-2033)
Table 100. Global Pegfilgrastim Biosimilar Sales Growth Rate by Application (2020-2033)
Table 101. Novartis Basic Information
Table 102. Novartis Pegfilgrastim Biosimilar Product Overview
Table 103. Novartis Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Novartis Business Overview
Table 105. Novartis SWOT Analysis
Table 106. Novartis Recent Developments
Table 107. Mylan Basic Information
Table 108. Mylan Pegfilgrastim Biosimilar Product Overview
Table 109. Mylan Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Mylan Business Overview
Table 111. Mylan SWOT Analysis
Table 112. Mylan Recent Developments
Table 113. Coherus BioSciences Basic Information
Table 114. Coherus BioSciences Pegfilgrastim Biosimilar Product Overview
Table 115. Coherus BioSciences Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Coherus BioSciences Business Overview
Table 117. Coherus BioSciences SWOT Analysis
Table 118. Coherus BioSciences Recent Developments
Table 119. Mundipharma International Basic Information
Table 120. Mundipharma International Pegfilgrastim Biosimilar Product Overview
Table 121. Mundipharma International Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Mundipharma International Business Overview
Table 123. Mundipharma International Recent Developments
Table 124. Biocon Basic Information
Table 125. Biocon Pegfilgrastim Biosimilar Product Overview
Table 126. Biocon Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Biocon Business Overview
Table 128. Biocon Recent Developments
Table 129. Intas Pharmaceuticals Basic Information
Table 130. Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Overview
Table 131. Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Intas Pharmaceuticals Business Overview
Table 133. Intas Pharmaceuticals Recent Developments
Table 134. Pfizer Basic Information
Table 135. Pfizer Pegfilgrastim Biosimilar Product Overview
Table 136. Pfizer Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Pfizer Business Overview
Table 138. Pfizer Recent Developments
Table 139. Dr Reddy’s Laboratories Basic Information
Table 140. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Overview
Table 141. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Dr Reddy’s Laboratories Business Overview
Table 143. Dr Reddy’s Laboratories Recent Developments
List of Figures
Figure 1. Product Picture of Pegfilgrastim Biosimilar
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pegfilgrastim Biosimilar Market Size (M USD), 2024-2033
Figure 5. Global Pegfilgrastim Biosimilar Market Size (M USD) (2020-2033)
Figure 6. Global Pegfilgrastim Biosimilar Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pegfilgrastim Biosimilar Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pegfilgrastim Biosimilar Product Life Cycle
Figure 13. Pegfilgrastim Biosimilar Sales Share by Manufacturers in 2024
Figure 14. Global Pegfilgrastim Biosimilar Revenue Share by Manufacturers in 2024
Figure 15. Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pegfilgrastim Biosimilar Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pegfilgrastim Biosimilar Revenue in 2024
Figure 18. Industry Chain Map of Pegfilgrastim Biosimilar
Figure 19. Global Pegfilgrastim Biosimilar Market PEST Analysis
Figure 20. Global Pegfilgrastim Biosimilar Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Pegfilgrastim Biosimilar Market Size by Region
Figure 27. Global Pegfilgrastim Biosimilar Market Size Market Share by Region (2020-2033)
Figure 28. Global Pegfilgrastim Biosimilar Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Pegfilgrastim Biosimilar Market Size (M USD) by Country
Figure 33. USA Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Pegfilgrastim Biosimilar Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Pegfilgrastim Biosimilar Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Pegfilgrastim Biosimilar Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Pegfilgrastim Biosimilar Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Pegfilgrastim Biosimilar Market Size (M USD)by Type
Figure 40. North America Pegfilgrastim Biosimilar Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Pegfilgrastim Biosimilar Market Size (M USD) by Country
Figure 45. Germany Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Pegfilgrastim Biosimilar Market Size (M USD) by Type
Figure 56. Europe Pegfilgrastim Biosimilar Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Pegfilgrastim Biosimilar Market Size (M USD) by Country
Figure 61. China Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Pegfilgrastim Biosimilar Market Size (M USD) by Type
Figure 72. Asia-Pacific Pegfilgrastim Biosimilar Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Pegfilgrastim Biosimilar Market Size (M USD) by Country
Figure 77. Brazil Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Pegfilgrastim Biosimilar Market Size (M USD) by Type
Figure 84. South America Pegfilgrastim Biosimilar Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Pegfilgrastim Biosimilar Market Size (M USD) by Country
Figure 89. Saudi Arabia Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Pegfilgrastim Biosimilar Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Pegfilgrastim Biosimilar Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Pegfilgrastim Biosimilar Market Size (M USD) by Type
Figure 100. Middle East and Africa Pegfilgrastim Biosimilar Market Size (M USD) by Application
Figure 101. Global Pegfilgrastim Biosimilar Production Market Share by Region (2020-2025)
Figure 102. North America Pegfilgrastim Biosimilar Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Pegfilgrastim Biosimilar Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Pegfilgrastim Biosimilar Production (K MT) Growth Rate (2020-2025)
Figure 105. China Pegfilgrastim Biosimilar Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Pegfilgrastim Biosimilar Market Size by Type (M USD)
Figure 108. Sales Market Share of Pegfilgrastim Biosimilar by Type (2020-2033)
Figure 109. Sales Market Share of Pegfilgrastim Biosimilar by Type in 2024
Figure 110. Market Size Share of Pegfilgrastim Biosimilar by Type (2020-2033)
Figure 111. Market Size Share of Pegfilgrastim Biosimilar by Type in 2024
Figure 112. Global Pegfilgrastim Biosimilar Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Pegfilgrastim Biosimilar Market Size by Application(M USD)
Figure 115. Global Pegfilgrastim Biosimilar Market Share by Application
Figure 116. Global Pegfilgrastim Biosimilar Sales Market Share by Application (2020-2033)
Figure 117. Global Pegfilgrastim Biosimilar Sales Market Share by Application in 2024
Figure 118. Global Pegfilgrastim Biosimilar Market Share by Application (2020-2033)
Figure 119. Global Pegfilgrastim Biosimilar Market Share by Application in 2024
Figure 120. Global Pegfilgrastim Biosimilar Sales Growth Rate by Application (2020-2033)